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Abstract
Background: Cigarette smoke (CS) is the major etiologic factor of chronic obstructive pulmonary disease (COPD).
CS-exposed mice develop emphysema and mild pulmonary inflammation but no airway obstruction, which is also
a prominent feature of COPD. Therefore, CS may interact with other factors, particularly respiratory infections, in the
pathogenesis of airway remodeling in COPD.
Methods: C57BL/6 mice were exposed to CS for 2 h a day, 5 days a week for 8 weeks. Mice were also exposed to
heat-killed non-typeable H. influenzae (HK-NTHi) on days 7 and 21. One day after the last exposure to CS, mice were
sacrificed and lung inflammation and mechanics, emphysematous changes, and goblet cell metaplasia were
assessed. Mice exposed to CS or HK-NTHi alone or room air served as controls. To determine the susceptibility to
viral infections, we also challenged these mice with rhinovirus (RV).
Results: Unlike mice exposed to CS or HK-NTHi alone, animals exposed to CS/HK-NTHi developed emphysema, lung
inflammation and goblet cell metaplasia in both large and small airways. CS/HK-NTHi-exposed mice also expressed
increased levels of mucin genes and cytokines compared to mice in other groups. CS/HK-NTHi-exposed mice
infected with RV demonstrated increased viral persistence, sustained neutrophilia, and further increments in mucin
gene and chemokine expression compared to other groups.
Conclusions: These findings indicate that in addition to CS, bacteria may also contribute to development of COPD,
particularly changes in airways. Mice exposed to CS/HK-NTHi are also more susceptible to subsequent viral infection
than mice exposed to either CS or HK-NTHi alone.
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Background
Chronic obstructive pulmonary disease (COPD) is the
fourth leading cause of death world-wide, and the preva-
lence of COPD is increasing globally [1]. COPD is char-
acterized by airflow limitation that is progressive and is
usually irreversible. Small airway remodeling, including
narrowing of airways due to peribronchiolar fibrosis,
goblet cell metaplasia and excessive mucus production,
is now accepted as an important cause of airflow ob-
struction in COPD [2]. In addition, lung parenchyma is
destroyed by proteolytic damage (emphysema), reducing
the elasticity and gas-exchange surface area of the lung.
Acute exacerbations further enhance airways obstruction
and accelerate progression of lung disease in these pa-
tients (reviewed in [3]). However, the underlying mecha-
nisms for these changes are not well understood, partly
because small-animal models do not recapitulate all the
typical features of human COPD.
COPD has been modeled in mice by administration of
proteases, lipopolysaccharide (LPS), chemicals and cigarette
smoke (CS). In particular, CS has been used extensively to
investigate mechanisms of COPD pathogenesis since it is
the major risk factor in the development of COPD [3].
While whole body exposure to CS for a short-term (3 days
to 4 weeks) has been useful in evaluating the mechanisms
of CS-induced acute lung inflammation and defective
* Correspondence: usajjan@umich.edu
1Department of Pediatrics and Communicable Diseases, University of
Michigan, 1150 W. Medical Center Dr., Ann Arbor, MI 48109-5688, USA
Full list of author information is available at the end of the article
© 2014 Ganesan et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication
waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise
stated.
Ganesan et al. Respiratory Research 2014, 15:11
http://respiratory-research.com/content/15/1/11
innate immune responses to subsequent infections [4-7],
long-term exposure to CS for periods up to 6 months has
been employed to understand the mechanisms of emphy-
sema development [8-11]. However, neither of these models
show changes in small airways, which plays a major role in
the development of airflow limitation in COPD implying
that other factors in addition to CS are required to mimic
COPD lung disease in mice [12].
Although CS exposure is the key insult in the patho-
genesis of COPD, only 25 to 35% of smokers develop
COPD [13,14] suggesting the contribution of other fac-
tors, such as genetic background, concurrent respiratory
infections, and aberrant host responses in the develop-
ment of COPD. Respiratory pathogens including bac-
teria, viruses and fungi are often present in the airways
of COPD patients and therefore it is plausible that re-
spiratory pathogens or their products such as entero-
toxin, endotoxin, viral RNA may contribute to disease
pathogenesis [15-17]. For example Kang et al. demon-
strated that CS synergizes with synthetic double
stranded (ds) RNA, a viral RNA mimetic to induce en-
hanced inflammatory and emphysematous changes, and
airway fibrosis in the mouse lungs [17]. However these
mice did not develop goblet cell metaplasia, increased
mucus production or airways obstruction, which are also
important features of COPD. Similar results were ob-
served when mice were infected with influenza virus in-
stead of treating with dsRNA. Enterotoxin B isolated
from S. aureus was shown to exacerbate CS-induced in-
flammatory changes in mouse lungs and induce goblet
cell metaplasia and formation of lymphoid aggregates,
but these mice did not develop emphysema. Chronic ex-
posure of mice to lysates of non-typeable H. influenzae
(NTHi) was shown to induce airway inflammation but
not emphysema or airway remodeling [18]. Endotoxin, a
bacterial cell wall component is present in abundant
amounts as a contaminant in CS [19,20] and prolonged
intratracheal exposure of mice to endotoxin, (twice week
for 3 months) induces lung inflammation, and changes
in both parenchyma and airways which persists up to
8 weeks [21]. We demonstrated that exposure of mice
once a week to combination of elastase and endotoxin
for 4 weeks induces all the features of COPD [22]. The
latter three models although exhibit features of COPD
and indicate involvement of bacterial factors in COPD
pathogenesis, these models may not be representative of
CS-induced changes. Based on these observations, in the
present study we examine a novel concept that in
addition to CS, exposure to bacteria is required to in-
duce typical features of COPD including emphysema,
airway remodeling, and lung inflammation in mice.
Since NTHi is frequently isolated from clinically stable
COPD patients as well as during exacerbations [23], we
used NTHi in the present study. We also evaluated
susceptibility to rhinovirus (RV) infection in this model,
because RV is associated with virally mediated exacerba-
tions of COPD and sometimes leads to progression of
lung disease [24,25].
Methods
Animals and treatment
Eight to ten week old C57BL/6 mice (Charles River
Laboratories, Wilmington, MA) were exposed to CS as de-
scribed previously [26]. Briefly mice were exposed to smoke
from standardized 3R4F research cigarettes (University of
Kentucky, Lexington, KY) generated by a TE-2 cigarette
smoking machine (Teague Enterprises, Woodland, CA).
This device is set up to provide a mixture of mainstream
and sidestream smoke. Animals were exposed to CS
for 2 h/day, 5 days/week for 8 consecutive weeks in a
54-L glass and Plexiglas whole-body exposure chamber
with an electric fan for chamber mixing in standard
mouse caging units with wire cage tops, with water
available ad libitum. The mean concentration of particulates
collected during a 2-h exposure was 9.28 ± 1.45 mg/day.
Control mice were exposed to room air (RA) under similar
conditions. Heat-killed (HK) NTHi was administered into
the lungs on days 7 and 21 by intranasal route. Three days
after the last exposure to CS, lungs were lavaged [27] to
determine total and differential cell counts and to
measure cytokines, were fixed in formalin and embed-
ded in paraffin [22] to evaluate morphology, or were
homogenized in PBS to isolate total RNA. In additional
experiments, mice were inoculated intranasally with
RV or with a sham preparation, and sacrificed 4 days
post infection. All experiments were approved by the
Animal Care and Use Committee of the University of
Michigan and Veterans Affairs, Ann Arbor Medical
Center Animal Care Committee.
Heat killed bacteria
NTHi strain, 5P54H1 was isolated from a COPD pa-
tient and was kindly provided by Dr. Timothy Murphy,
University of Buffalo. Bacteria were cultured on chocolate
agar, suspended in PBS to density of 1 × 109 CFU/ml and in-
cubated at 80°C for 30 min to kill the bacteria. Mice received
50 μl of heat-killed (HK) NTHi or PBS intranasally [28].
Rhinovirus and infection
Stocks of RV1B were prepared by infecting HeLa cells
with RV1B and subjecting HeLa cell supernatants to
ultrafiltration and then viral titer was determined as de-
scribed previously [22,29]. Similarly concentrated and
purified cell supernatants from uninfected HeLa cells
were used as sham controls. At the end of 8 weeks of ex-
posure to CS or RA and +/− HK-NTHi, mice were in-
fected with RV or an equal volume of sham preparation
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by intranasal route as described previously [22] and
sacrificed 4 days post infection.
Bronchoalveolar Lavage (BAL)
After relevant treatment, mice were sacrificed and BAL
was performed by instilling 1 ml PBS containing 5 mM
EDTA 10 times [27]. The first wash was centrifuged and
supernatant was retained for determination of cytokines
by ELISA. Cells from the first wash were combined with
the cells from rest of the washes and suspended in 1 ml
of PBS and numbers of cells were counted to determine
total cells. Cytospins prepared from BAL cells were
stained with Diff-Quick and differential counts were de-
termined by counting a minimum of 200 cells.
RNA isolation and qPCR
Lungs were collected under aseptic conditions after rele-
vant treatment and homogenized in 2 ml PBS. An ali-
quot of lung homogenate was immediately mixed with
TRIZOL and total RNA was then purified by using
RNeasy miRNA kit (Qiagen, Alameda, CA). Total RNA
was reverse transcribed to first strand cDNA using Taq-
man reverse transcription kit (Applied Biosystems Life
Technologies, Carlsbad, CA). cDNA was then used to
determine the mRNA expression of IP-10, Muc5B,
Muc5AC, Gob5 and G3PDH (house-keeping gene) by
quantitative qPCR using gene specific primers and Syber
green PCR mix. All primers were designed and pur-
chased from IDT (Coralville, IA). To detect viral RNA,
total RNA isolated from the lungs was subjected quanti-
tative Taqman qPCR as described previously [30] and
expressed as number of vRNA copies per 10 μg of total
RNA.
Infectious viral load
Lung homogenates were used to determine the infec-
tious viral load by plaque assay as described [22].
Histology and morphometry
Lungs were inflation fixed at a constant pressure of 30 cm.
H2O for 30 min. Lungs were embedded in paraffin, and 5 μ
thick sagittal sections were stained with hematoxylin and
eosin (H & E) to assess histology or periodic acid-Schiff
(PAS) to detect goblet cells. Alveolar chord length was de-
termined as described previously [22,31]. Briefly, sagittal
sections obtained at 5 mm intervals through the depth of
the lungs were stained with H & E and the diameters of the
air spaces measured in at least 10 random areas using NIH
image J analysis software. Sagittal sections obtained at
5 mm intervals were also stained with PAS and the number
of PAS positive cells per 100 μM basement membrane
lengths was counted in random fields. Airways with perim-
eter of ≤1 mM were considered as small airways. Airways
with cartilage were considered as large airways [22].
Lung mechanics and airways resistance
Dynamic lung elastance and compliance, pressure-
volume relationship in mice exposed to RA, CS, RA/
HK-NTHi or CS/HK-NTHi, were measured as described
previously using a miniature computerized flexivent ven-
tilator (Scireq, Canada) [22]. Airways responsiveness to
increasing dose of methacholine challenge following RV
infection was measured by plethysmography [30].
ELISA
Bronchoalveolar lavage fluid was centrifuged and the
supernatant was used for assessing the levels of chemo-
kines and cytokines by ELISA.
Statistical Analysis
Results are expressed as means ± SD or mean with range
of data. Data were analyzed by using SigmaStat statistical
software (Systat Software, San Jose, CA). One- or two-
way ANOVA with Tukey’s range test, ANOVA on ranks
with Friedman’s test or unpaired t test was performed as
appropriate to compare groups and a P value ≤ 0.05 was
considered significant.
Results
Lung histology
Lung sections from mice exposed to room air (RA), RA/
HK-NTHi, CS, CS-HK-NTHi were evaluated by light
microscopy. RA-exposed mice showed normal morph-
ology with baseline air space size and no appreciable in-
flammation (Figure 1A and 1B). CS-exposed mice
showed mild lung inflammation, enlarged airspaces in a
patchy distribution, and accumulated inflammatory cells
(possibly macrophages) in the airspaces (Figure 1C
and 1D). Mice exposed to HK-NTHi showed no en-
larged airspaces, but demonstrated peribronchiolar in-
flammation (Figure 1E to 1H). Mice treated with a
combination of CS and HK-NTHi showed enlarged air-
spaces and mild lung inflammation (Figure 1I), as well
as accumulation of inflammatory cells in peribronchiolar
and perivascular areas (Figure 1J and 1K) and in the air-
spaces (Figure 1L). Compared to RA- or CS-exposed
mice, both HK-NTHi and CS/HK-NTHi-exposed mice
showed increases in the numbers of PAS positive cells
(indicative of goblet cell metaplasia) in large airway epi-
thelia, however it was more pronounced in CS/NK-
NTHi-exposed mice (Figure 2A to 2D). Mice in CS/HK-
NTHi group, but not animals in other groups showed
increased numbers of PAS positive cells in small airway
epithelia (Figure 2E to 2H). Mice exposed to HK-NTHi
or CS/HK-NTHi also showed airway epithelial hyperpla-
sia in both small and large airways, but it was more
prominent in CS/HK-NTHi-exposed mice.
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Morphometry and lung mechanics
Morphometric analysis was performed to determine the
mean airspace chord length. Compared to RA-exposed
mice both CS- and CS/HK-NTHi-exposed mice showed
small but significant increases in chord length (RA vs CS,
p = 0.045; RA vs CS/HK-NTHi, p = 0.002) (Figure 3A), but
mice exposed to HK-NTHi did not. The changes in chord
length in mice exposed to combination of CS and HK-
NTHi were higher than in mice exposed to CS alone
(p = 0.031).
We assessed elasticity of the lungs by determining total
respiratory system compliance, elastance, and the pressure-
volume (P-V) relationships during inflation. Compared to
RA- or HK-NTHi-exposed mice, CS and CS/HK-NTHi-
exposed mice showed increased compliance (CS vs RA,
p = 0.047; CS vs HK-NTHi, p = 0.039; CS/HK-NTHi vs
RA, p = 0.022; CS/HK-NTHi vs HK-NTHi, p = 0.029)
(Figure 3B). Conversely, a significant decreases in elastance
(Figure 3C) were observed in CS or CS/HK-NTHi group
compared to mice exposed to RA or HK-NTHi (CS vs RA,
p = 0.038; CS vs HK-NTHi, p = 0.025, CS/HK-NTHi vs RA,
p = 0.011; CS/HK-NTHi vs HK-NTHi, p = 0.007). However,
the changes in both compliance and elastance were signifi-
cantly higher in CS/HK-NTHi-exposed mice than in CS-
exposed mice (compliance, p = 0.034 and elastance,
p = 0.021). Consistent with these observations, we also
observed slightly upward and leftward shifts in the P-V re-
lationships in CS- and CS/HK-NTHi-exposed mice com-
pared to mice in other two groups, demonstrative of
reduced elastic recoil. However, the changes in P-V rela-
tionship were more pronounced in CS/HK-NTHi-exposed
mice (Figure 3D).
Figure 1 Histological evaluation of lungs. Lungs harvested from mice exposed to RA (A and B), CS (C and D), HK-NTHi (E to H) or
CS/HK-NTHi (I to L) were inflation fixed in formalin, and embedded in paraffin. Five micron thick sections were stained with H&E and observed
under light microscope. Arrows in D and L represent infiltrated inflammatory cells in alveolar space. G and K represent magnified view of marked
area in F and J respectively and show accumulated macrophages in peribronchiolar area. Asterisks in D and I represents emphysema. Images are
representative of 3–4 mice per group.
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Figure 2 (See legend on next page.)
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Airways inflammation and mucin gene expression
To assess lung inflammation, we performed total and differ-
ential cell counts and quantified levels of IL-1β, TNF-α, KC
and MCP-1 by ELISA. Compared to mice exposed to RA
or CS, mice in HK-NTHi and CS/HK-NTHi groups
showed a significantly higher numbers of total cells (RA vs
HK-NTHi, p = 0.043; CS vs HK-NTHi, p = 0.048; RA vs
CS/HK-NTHi p = 0.013; CS vs CS/HK-NTHi, p = 0.025)
with the largest increase observed in the CS/HK-NTHi
group (HK-NTHi vs CS/HK-NTHi, p = 0.0103) (Figure 4A).
Both macrophages (Figure 4B) and lymphocytes were
higher (Figure 4C) in the airways of CS/HK-NTHi than in
RA-exposed mice (p = 0.027 and p = 0.031 respectively).
Only the number of lymphocytes increased significantly in
CS, HK-NTHi-exposed mice compared to RA-exposed
mice (p = 0.049 and p = 0.043 respectively). There were no
significant differences in numbers of neutrophils among the
groups (data not shown). We then examined the levels of
cytokines in the lavage fluid (Figure 4D to 4G). Compared
to mice exposed to RA, mice in all other groups showed
more IL-1β (RA vs CS, p = 0.043; RA vs HK-NTHi,
p = 0.042; RA vs CS/HK-NTHi, p = 0.037) and KC levels
(RA vs CS, p = 0.010; RA vs HK-NTHi, p = 0.007; RA vs
CS/HK-NTHi, p = 0.023). Mice in HK-NTHi or CS/HK-
NTHi groups, but not in the CS group showed higher
levels of MCP-1 (RA vs HK-NTHi, p = 0.042; RA vs CS/
HK-NTHi, p = 0.001) and TNF-α (RA vs HK-NTHi,
p = 0.049; RA vs CS/HK-NTHi, p = 0.02) than the RA
group. However, mice in the CS/HK-NTHi group showed
the highest increases in the levels of all the cytokines
measured.
We then measured the expression of mucin genes,
Muc5B and Muc5AC and a calcium-activated chlor-
ide channel that is thought to regulate mucus pro-
duction and/or secretion, Gob5 (mclca3) [32] by
qPCR. The expression of Muc5AC and Gob5, but
(See figure on previous page.)
Figure 2 PAS staining of lung sections. Paraffin lung sections were stained with PAS to determine goblet cell metaplasia in large and small
airways. A to D, represents large airways and F to I represents small airways from mice exposed to RA, CS, HK-NTHi and CS/HK-NTHi respectively.
Arrows in C, D and I represents cells positive for PAS, a marker of goblet cells. Number of PAS positive cells in large (E) and small (J) airway
epithelia were counted in at least 10 random fields per slide and expressed as number of goblet cells/100 μM basement membrane length.
Data represents median with range calculated from 5–6 mice (* different from RA-exposed mice, p≤ 0.05, ANOVA on ranks; # different from CS-
exposed mice, p≤ 0.05, ANOVA on ranks; † different from HK-NTHi-exposed mice, p≤ 0.05, ANOVA on ranks). Airway epithelial hyperplasia is
observed in large airways of HK-NTHi (C) and both large (D) and small (H) airways of CS/HK-NTHi exposed mice. Images are representative of 5–6
mice per group.
Figure 3 Morphometry and lung mechanics. (A) Lungs of mice exposed to RA, CS, HK-NTHi or CS/HK-NTHi were inflated to an identical
pressure, processed for paraffin embedding and sections at different depth were stained with H & E. The diameters of the air spaces were
measured in at least 10 random fields per slide.. Mice were anesthetized and dynamic compliance (B) and elastance (C) and pressure-volume
relationships (D) were measured using Flexivent system. Data in A to C represent median with range calculated from 5 to 6 mice per group
(* different from RA-exposed mice, p ≤ 0.05, ANOVA on ranks; # different from RA/HK-NTHi-exposed mice, p≤ 0.05, ANOVA on ranks; † different
from CS-exposed mice, p≤ 0.05, ANOVA on ranks).
Ganesan et al. Respiratory Research 2014, 15:11 Page 6 of 13
http://respiratory-research.com/content/15/1/11
not Muc5B was increased in HK-NTHi-exposed mice
compared to RA-exposed, but not in CS-exposed
mice (Muc5AC- RA vs HK-NTHi, p = 0.041; Gob5-
RA vs HK-NTHi, p = 0.038) (Figure 5A to 5C). In
contrast, CS/HK-NTHi-exposed mice showed in-
creases in Muc5B (p = 0.041) and Muc5AC
(p = 0.045) as well as Gob5 (p = 0.039) compared to
RA-exposed mice. Again CS/HK-NTHi mice showed
the largest increases in expression in all three genes.
Susceptibility to RV infection
At the end of 8 weeks of exposure to CS, mice were in-
fected with RV or sham, sacrificed after 4 days and ex-
amined for viral RNA, chemokine expression, neutrophil
infiltration and mucin gene expression. CS/HK-NTHi-
exposed mice infected with RV showed one log higher
vRNA than similarly infected animals in other groups
(p = 0.024) (Figure 6A). CS/HK-NTHi mice also showed
higher infectious viral load than mice in other groups
Figure 4 Lung inflammation. Bronchoalveolar lavage from RA, CS, HK-NTHi or CS/HK-NTHi mice was centrifuged and the pellet was used to
determine total (A) and differential cell (B and C) counts. Supernatant was used to determine levels of IL-1β (D), TNF-α (E), MCP-1 (F) and KC (G)
by ELISA. Data in A to C and D to G respectively represent median with range and mean ± SD calculated from 5–6 mice per group (* different
from RA-exposed mice, p≤ 0.05, ANOVA on ranks in A to C and ANOVA in D to G; # different from CS-exposed mice, p≤ 0.05, ANOVA on ranks in
A to C and ANOVA in D to G; † different from HK-NTHi-exposed mice, ANOVA on ranks in A to C and ANOVA in D to G).
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(p = 0.007), but it was only 1 to 2 × 102 PFU/lung
(Figure 6B). Despite having low levels of infectious viral
load, the CS/HK-NTHi group showed remarkably higher
neutrophil (p = 0.001) and lymphocyte (p = 0.009) infil-
tration compared to the sham infected group (Figure 6C
and 6D). Consistent with the cellular infiltration, CS/
HK-NTHi mice infected with RV also showed persistent
increases in KC (p = <0.001), MIP-2 (p = 0.001) and IP-
10 (0.022), compared to sham infected mice (Figure 6E-
6G). RV infected mice in other groups showed very
small increases in infiltrated neutorphils, lymphocytes
and cytokine levels over their respective sham-infected
controls (p values ranged between 0.039 to 0.05 in these
animals).
To assess the effects of RV infection on airways ob-
struction, we examined the expression of mucin genes,
Gob5, goblet cell metaplasia in small airways, and re-
sponses to methacholine challenge. Irrespective of infec-
tion, mice exposed to RA, CS or RA/HK-NTHi did not
show changes in the expression of Muc5B, Muc5AC or
Gob5 (data not shown). In contrast, CS/HK-NTHi-ex-
posed mice infected with RV showed additional increases
in the expression of Muc5AC (p = 0.041) and Gob5
(p = 0.003), but not muc2B compared to similarly-
exposed sham-infected mice (Figure 7A to 7C). CS/HK-
NTHi-exposed mice infected with RV also showed a
further increment in PAS-positive cells in the small air-
ways compared to sham-infected mice, implying that en-
hanced mucus expression may be due to increased
goblet cell metaplasia in these mice (Figure 7D and 7E).
In contrast, mice exposed to RA, CS or RA/HK-NTHi
infected with RV did not show an increase in either the
expression of mucin genes or the number of goblet cells
in the airway epithelium (data not shown).
RV-infected mice, irrespective of prior exposure to CS.
NTHi, or combination of CS/NTHi, showed an increase
in airways resistance in response to methacholine chal-
lenge over respective sham-infected mice (Figure 8A to
8D). However, CS/HK-NTHi-exposed mice infected with
RV showed a much higher increase in airways resistance
to methacholine challenge than similarly infected mice
in other groups.
Taken together these results demonstrate that in
addition to CS, bacterial products may also be required
to induce COPD-like changes in both parenchyma and
conducting airways of mice, and that CS/HK-NTHi-ex-
posed mice are also more susceptible to subsequent RV
infection.
Discussion
Exacerbations in COPD patients are characterized by in-
creased inflammation and increased lower respiratory
Figure 5 Expression of mucin genes, Muc5B and Muc5AC and Gob5. Total RNA was isolated from the lungs of mice exposed to RA, CS,
HK-NTHi or CS/HK-NTHi and mRNA expression of Muc5B (A), Muc5AC (B) and Gob5 (C) was assessed by qPCR and expressed as fold change over
house-keeping gene, G3PDH. Data represents mean ± SD calculated from 6 mice per group (* different from RA-exposed mice, p≤ 0.05, ANOVA;
# different from CS-exposed mice, p≤ 0.05, ANOVA; † different from HK-NTHi-exposed mice, p≤ 0.05, ANOVA).
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tract symptoms requiring change in therapy such as
treatment with antibiotics, steroids or antiviral drugs
[33]. Exacerbations may be triggered primarily by viral or
bacterial infections and are often associated with acceler-
ated progression of lung disease. RV, which causes self-
limiting infections in healthy individuals is responsible for
the majority of virus-related exacerbations in patients with
COPD [24,25], but the underlying mechanisms are not well
understood. In this study, we developed a mouse model
which displays phenotypic characteristics of COPD, includ-
ing emphysema, mild but diffuse lung inflammation, and
goblet cell metaplasia. We combined this model with our
previously described mouse model of RV infection [22,34]
and show that these mice show prolonged neutrophilic
lung inflammation and airways obstruction, similar to that
observed in mild COPD patients experimentally infected
with RV [35], indicating the suitability of this model to elu-
cidate mechanisms of COPD exacerbations.
Figure 6 Assessment of susceptibility of RA, CS, HK-NTHi or CS/HK-NTHi-exposed mice to RV infection. RA, CS, HK-NTHi or CS/HK-NTHi-
exposed mice were either infected with RV or equal volume of sham and mice were sacrificed 4 days post-infection. (A) Total RNA was isolated
from whole lungs and viral RNA (vRNA) copy number was determined by quantitative qPCR and expressed vRNA copy number per 10 μg of total
RNA. (B) Lung homogenates were used to determine infectious viral load by assessing number of plaque forming units (PFU) per lung. (C and D).
Cells from bronchoalveolar lavage were used to determine number of neutrophils and lymphocytes and expressed as cells/ml of BAL. Data in A
to D represent median with range calculated from 5 to 6 mice per group (* different from RA-exposed mice, p ≤ 0.05, ANOVA on ranks;
# different from CS-exposed mice, p ≤ 0.05, ANOVA on ranks; † different from HK-NTHi-exposed mice, p ≤ 0.05, ANOVA on ranks). (E and F)
Supernatants from bronchoalveolar lavage were used to determine KC and MIP2 levels. (G) Total lung RNA was reverse transcribed and subjected
to qPCR to determine mRNA levels of IP-10 and expressed as fold change over house-keeping gene, G3PDH. Data in E to G represents mean ± SD
calculated from 5–6 mice per group (* different from respective sham controls, p ≤ 0.05, ANOVA; # different from CS-exposed RV-infected
mice, p ≤ 0.05, ANOVA; † different from HK-NTHi-exposed RV-infected mice, p ≤ 0.05, ANOVA).
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The mouse model of COPD developed in this study
supports our primary hypothesis that both CS and bac-
teria are required for development of COPD–like
changes in mice and also render mice susceptible to viral
infection. We demonstrate that although CS is the major
risk factor in the development of COPD, mice exposed
to CS alone for 8 weeks only develop mild lung inflam-
mation and emphysema but not small airway disease
which is consistent with previous observations [4,8-11].
In contrast, exposure of mice to a combination of CS
and NTHi induces not only more pronounced emphy-
sema and lung inflammation than mice exposed to CS
alone, but also goblet cell metaplasia in the airways,
which is one of the pathologic features of COPD. In
addition, mice exposed to combination of CS/HK-NTHi
also show heightened susceptibility to viral infection
with further increases in lung inflammation and goblet
cell metaplasia. Together, these findings suggest that this
novel mouse model of COPD is not only useful in un-
derstanding the mechanisms of exacerbations, but also
for delineating the mechanisms underlying progression
of lung disease in COPD. However, it should be noted
that continuous exposure to CS and/or intermittent in-
fection with bacteria or virus may be required to main-
tain chronicity of the COPD-like changes in these mice.
NTHi is one of the more commonly isolated organ-
isms from clinically stable COPD patients and also at
exacerbations [23], and patients who are chronically col-
onized with NTHi show significantly more neutrophilic
airway inflammation than those who are not colonized
[15,36]. Further, repeated exposure to extracts of heat-
killed NTHi causes airway inflammation in mice with
cellular and cytokine profiles similar to COPD [18]. Fi-
nally, NTHi products increase mucin gene expression
in vivo and in vitro [37]. These observations indicate
that NTHi may contribute to the development of COPD
particularly, small airway disease and lung inflammation.
Based on these facts, we postulated that NTHi may
synergize with CS to induce development of COPD-like
features in mice which includes changes in both small
airways and parenchyma. In the present study, we opted
to use low-dose (5 × 106 CFU) heat-killed NTHi
to induce milder and sustained inflammation with min-
imal infiltration of neutrophils as opposed to acute
neutrophil-dominated inflammation induced by live
NTHi [27,28], to prevent extensive lung damage. The
bacterial dose was chosen based on our preliminary ex-
periments, in which mice were treated with heat-killed
bacteria equivalent to 5 × 105, 5 × 106 or 5 × 107 CFU
once a week for 4 consecutive weeks and sacrificed
4 weeks after the last treatment. By morphology, mice
treated with 5 × 105 CFU did not show any detectable
changes in the lungs and were very similar to untreated
mice. In contrast, mice treated with 5 × 107 CFU
Figure 7 Expression of mucin genes and goblet cell metaplasia in CS/HK-NTHi-exposed mice following RV-infection. CS/HK-NTHi-
exposed mice were infected with RV or equal volume of sham and sacrificed 4 days later. (A to C) Total lung RNA was isolated, reverse
transcribed and subjected to qPCR using gene specific primers and expressed as fold change over house-keeping gene, G3PDH. Data in E to G
represents mean ± SD calculated from 5–6 mice per group (* different from sham infected mice, p≤ 0.05, unpaired t test). (D and E) Paraffin lung
sections from sham- or RV-infected animals were stained with PAS. Arrows point to PAS positive goblet cells. Images are representative of 3
animals per group.
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showed severe lung inflammation, consolidation of par-
enchyma and pronounced goblet cell metaplasia in both
small and large airways. Mice treated with 5 × 106 CFU
showed mild to moderate lung inflammation with mild
goblet cell metaplasia. In addition, we also found that
two exposures to 5 × 106 CFU instead of four exposures
were sufficient to induce these changes in the lung.
Combination of this HK-NTHi treatment with CS how-
ever, led to more pronounced lung inflammation and
goblet cell metaplasia, increased mucin gene expression
and also the development of emphysema. Interestingly
these mice also showed thickening of airway epithelia,
similar to the airway epithelial hyperplasia observed in
COPD patients [38]. We also observed aggregates of in-
flammatory cells particularly in the peribronchiolar and
perivascular areas resembling lymphoid aggregates [16],
but the nature of these aggregates is yet to be deter-
mined. We speculate that these pronounced pathological
changes in CS/HK-NTHi-exposed mice may be the re-
sult of exaggerated host innate immune responses to
bacterial products, in the presence of CS.
Alveolar macrophages in the lungs play an important role
in clearing bacteria and limit bacteria-induced inflamma-
tion. CS has been demonstrated to affect the function of al-
veolar macrophages by shifting their phenotype from M2
to M1 [39,40]. M1 macrophages respond to bacterial anti-
gens such as LPS by producing relatively more inflamma-
tory cytokines than M2 macrophages [41]. Although this is
required for clearance of bacteria, sustained production of
inflammatory cytokines may increase lung inflammation,
emphysema and also induce goblet cell metaplasia [8,42].
Based on these observations, we speculate that CS-induced
shift in macrophage phenotype may be one of the mecha-
nisms by which CS synergizes with NTHi to increase ex-
pression of inflammatory cytokines and this in turn may
lead to increased lung inflammation, emphysema and gob-
let cell metaplasia. Bacterial pathogens or their products
other than NTHi may also induce COPD-like changes
when combined with CS, but the magnitude of pathological
changes may vary depending on the bacteria used. How-
ever, further studies are required to confirm this notion.
CS/HK-NTHi-exposed mice displaying the COPD
phenotype were also found to be susceptible to subse-
quent infection with RV, a virus associated with a major-
ity of viral-associated COPD exacerbations [35,43]. Four
days after challenging with RV, CS/HK-NTHi-exposed
mice despite showing minimally higher viral loads than
similarly infected RA-, CS-, or NTHi-exposed mice, dis-
played sustained neutrophilia and lymphocyte infiltra-
tion, and increased expression of KC, MIP-2 and IP-10,
which was not observed in mice from other groups.
These changes were associated with progression in gob-
let cell metaplasia in small airways and increased expres-
sion of Muc5AC (mucin gene) and Gob5, a chloride
channel that plays a role in mucin secretion [32]. These
mice also showed sustained airways hyperresponsiveness
to methacholine challenge. Previously, we have shown
that airway epithelial cells isolated from COPD patients
are more susceptible to RV infection despite expressing
interferon and other antiviral genes [44]. This is prob-
ably due to increase in the number of goblet cells in
COPD cell cultures, because previously goblet cells have
Figure 8 Airways responsiveness to methacholine challenge following RV infection. RA, CS, HK-NTHi or CS/HK-NTHi-exposed mice were
either infected with RV or equal volume of sham. Four days later, total respiratory system resistance was measured by plethysmography. Data
represent mean ± SEM from 3 mice per group (* different from respective sham-infected animals, p ≤ 0.05, two-way ANOVA).
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been shown to be more permissive for RV infection [45].
Therefore it is plausible that CS/HK-NTHi mice which
show increased numbers of goblet cells in their airways
may be more susceptible to RV infection. In addition,
exposure to CS may also support replication of virus
and induce aberrant production of inflammatory cyto-
kines. Consistent with this notion, acute exposure to CS
was shown to increase production of pro-inflammatory
cytokines and reduce expression of antiviral genes in re-
sponse to RV infection in airway epithelial cells [46,47].
Such aberrant increases in inflammatory cytokines fol-
lowing RV infection may further enhance lung inflam-
mation, goblet cell metaplasia and airways obstruction.
However further studies are required to confirm this no-
tion. These observations are consistent with human
studies, in which mild COPD patients were shown to de-
velop sustained lower respiratory tract symptoms and in-
creased infiltration of neutrophil and lymphocyte in the
lungs after experimental rhinovirus infection [35]. These
changes correlated with decreases in lung function in
these patients. Another noteworthy observation is that
CS/HK-NTHi-exposed mice infected with RV also showed
sustained increases in IP-10 levels, which has been pro-
posed to be one of the biomarkers of COPD exacerbations
[48,49]. These similarities in responses to RV infection be-
tween COPD patients and CS/HK-NTHi mice imply that
this model may be useful in understanding the molecular
mechanisms related to viral-associated COPD exacerba-
tions and progression of lung disease.
Conclusions
In summary, we show that CS synergizes with NTHi to
cause a COPD-like phenotype in mice within a short
period of time. As far as we know, this is the first mouse
model of COPD to display innate immune responses to
RV infection similar to that observed in COPD patients.
Therefore we believe that this model could be used to
elucidate the mechanisms of disease progression follow-
ing acute exacerbations particularly that are associated
with viral infections. This model may also be useful to
model a chronic state of COPD, provided continuation
of exposure to CS in addition to intermittent administra-
tion of bacterial or viral products.
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